---
title: 'Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia:
  the EAS FH Studies Collaboration registry'
date: '2025-01-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39801189/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250113171006&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Overweight and obesity are common in patients with HeFH
  and contribute to ASCVD risk from childhood, independent of LDL-C and lipid-lowering
  medication. Sustained body weight management is needed to reduce the risk of ASCVD
  in ...'
disable_comments: true
---
CONCLUSIONS: Overweight and obesity are common in patients with HeFH and contribute to ASCVD risk from childhood, independent of LDL-C and lipid-lowering medication. Sustained body weight management is needed to reduce the risk of ASCVD in ...